Acquisition of General Grade Medication - Human Regular Insulin 100 IU/mL - 10 mL

The State of Rio de Janeiro is issuing a tender for the acquisition of Human Regular Insulin, a critical medication for the management of diabetes. Specifically, the tender calls for the supply of Insulin Regular Humana 100 IU/mL in 10 mL vials, categorized under the 'General Grade Medication' list. This type of insulin is a short-acting insulin used to control blood sugar levels, particularly around meal times, and is a fundamental component of diabetes treatment regimens. The procurement will be conducted through an electronic bidding process (Pregão Eletrônico), ensuring a competitive and transparent selection of suppliers. The objective is to ensure a consistent and reliable supply of this essential medication to public health facilities within the state, meeting the needs of diabetic patients. The tender documents will specify the required quantities, delivery timelines, packaging standards, and quality control measures. This acquisition reflects the State of Rio de Janeiro's commitment to providing essential medicines and comprehensive healthcare services to its residents, particularly those managing chronic conditions like diabetes.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Brazil, Latin America, this opportunity is open to firms and consortiums.

Published through PNCP Rio de Janeiro, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.